Chemomab Therapeutics Ltd. American Depositary Share CMMB
$1.72
-1.15%
at last close
Market Cap$12.38 million
P/E Ratio12.46
Div Yield—
Volume16.3K
52-Week Range
$1.35$5.88
Key Stats
- Today's Range
- $1.68 – $1.80
- 50-Day Range
- $1.45 – $2.14
- 52-Week Range
- $1.35 – $5.88
- Volume
- 16K shs
- Average Volume
- 48K shs
- Market Cap
- $12.38 million
- P/E Ratio
- 12.46
- Dividend Yield
- —
Valuation
- P/E Ratio
- 12.46
- Price / Book
- 0.44
- Price / Sales
- —
Short Interest
- Short Interest
- 0.17%
- Days to Cover
- 1.00
About Chemomab Therapeutics Ltd. American Depositary Share
Chemomab Therapeutics Ltd is a clinical-stage biotechnology company, focusing on the discovery and development of therapeutics for fibrosis-related diseases with large unmet needs. The company's candidate, CM-101, is a monoclonal antibody that targets CCL24 and was shown to interfere with the underlying biology of liver, skin, and lung fibrosis using a novel and differentiated mechanism of action. CM-101 has demonstrated the potential to treat multiple severe and life-threatening fibrotic and inflammatory diseases.
Related Stocks
Price and fundamental data are delayed and provided for informational purposes only. Not investment advice. See our disclaimer.